Wikipedia -WSS

Wikipedia

author：focus 2025-09-30 20:18:51 - browse：31

SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration end up relapsing or don’t respond to treatment, but new data presented at the annual American Society of Hematology meeting offer hope of a new targeted therapy for these patients.

The study, called the Phase 2 Augment-101 trial, tested Syndax’s revumenib in patients with relapsed or refractory leukemia with these KMT2A genetic rearrangements. Overall, about 63% of the patients responded to the treatment, with many able to receive a potentially curative stem cell transplant later on, which is often the ultimate goal for patients with relapsed or refractory patients, said Ibrahim Aldoss, a hematologist-oncologist at City of Hope and the study’s presenter, in an interview.

“KMT2A-rearranged diseases represent 10% of all leukemia. They can be exceptionally hard to treat,” Aldoss said. “The median overall survival remains low with current available treatment. Right now there’s no targeted therapy for KMT2A-rearranged disease. We’re really excited about revumenib as it targets the mutation, and we’re seeing encouraging outcomes.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Dexcom's push to bring CGM to type 2 diabetes patients

focus

leisure time

WSS

How Robert F. Kennedy Jr. distorted vaccine science

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

CDC advisory group OKs chikungunya vaccine

5 ways to address the shortage of health care workers

Color Health wants to make cancer screenings convenient

Vertex cell therapy lets patients with type 1 diabetes stop insulin

entertainment

Wikipedia

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Virtual repurposing can help discover new uses for existing drugs

The cancer drug shortage isn’t new — and neither are the solutions

Use doctors trained outside the U.S. to ease the physician shortage

Duchenne breakthrough therapy leaves behind pioneering families

Neuroscience renaissance leads to new crop of psychiatric drugs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Drug cartel violence flares in western Mexico after vigilante leader's killing

The high cost of giving birth even with insurance

What affirmative action's end means to a medical student

explore

Readout Newsletter: Beam, Prozac, "TechBio" and more

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Drug cartel violence flares in western Mexico after vigilante leader's killing

Hubble vs. James Webb telescope images: See the difference

Elisabeth Bik tackles the widespread issue of research misconduct

A letter from the executive editor: The 2023 STATUS List

explore

focus

leisure time

entertainment